{"id":"009ed5ca-8c47-4146-95ca-0ec9f1f68998","arxiv_id":"2510.03652","paper_version":2,"verdict":"REJECT","confidence":"MODERATE","novelty_score":4.0,"correctness_risk":"high","formal_verification":"none","parameter_count":4,"one_line_summary":"Parametric X-ray radiation is proposed as a tunable 2.4 keV source for selective sulfur K-edge tumor therapy, but the quantitative feasibility claims rest on an incorrect dose-volume model.","lead":"This paper proposes using parametric X-ray radiation tuned to the sulfur K-edge at 2.4 keV to selectively ionize sulfur atoms in tumors, which the authors say contain about three times more sulfur than healthy tissue. The idea could enable compact, selective X-ray therapy, but the dose and yield estimates contain internal errors that undermine the headline claim.","discovery_kind":"new_application","skeptic_critique":{"model":"deepseek-v4-flash","headline":"The dose estimate Eq. (29) uses a thermal-diffusion volume V≈8(at)^(3/2); radiation dose is deposited in the beam volume ΣL, so the 1.3 Gy figure is off by orders of magnitude and the claimed dose advantage over X-ray tubes is unsupported.","rationale":"The reader's weakest assumption is precisely the dose-volume model in Eq. (30), and this is the single most load-bearing point in the paper. The central conclusion that PXR gives a therapeutic dose of ~1.3 Gy with a two-orders-of-magnitude reduction relative to X-ray tubes depends entirely on this volume. A correct photon-transport picture, using the beam cross-section times penetration depth, gives a dose hundreds of times larger. Even a conservative version of the corrected estimate—using the paper's own ρ=4e3 kg/m^3 and L=1 mm—still gives ~180 Gy, which is far above the stated therapeutic window and destroys the claimed dose advantage. The mistake is not an internal inconsistency; it is a physically incorrect choice of deposition volume, and the paper provides no independent support (no simulation, no experiment) that would rescue the 1.3 Gy number. The internal numeric inconsistencies (Nph in Eq. 24 vs. Eq. 28, the 3e-4 vs. ~2e-5 value) further weaken confidence, but the dose-volume error alone is sufficient to reject the central quantitative claim. Since the reader already reached REJECT and this concern confirms that verdict, no adjustment is needed.","tokens_in":6101,"tokens_out":7618,"duration_ms":117967,"concrete_test":"Recompute Eq. (29) replacing V with V=ΣL, taking Σ=1 cm^2, L=1 mm (and alternatively L=1/μ from NIST XCOM at 2.472 keV), using Nph=3e11 s^-1, t=600 s, ρ=1e3 kg/m^3. If the dose is >100 Gy rather than ~1.3 Gy, Eq. (30)'s heat-diffusion volume is the cause and the central dose-reduction claim fails.","verdict_should_be":"UNCHANGED","load_bearing_attack":"The load-bearing quantitative claim is that PXR delivers D≈1.3 Gy (Eq. 31) and is two orders of magnitude better than an X-ray tube. This rests on Eq. (29) with the heat-diffusion volume V≈8(at)^(3/2) (Eq. 30). Absorbed radiation dose is not set by thermal diffusion; it is the energy deposited by the beam divided by the mass of the irradiated volume. The paper's own ionization rate, Eq. (26): N_S ≈ σ0 N0 L Nph, implies the deposition volume is ΣL, with Σ≈1 cm^2 and L≈1 mm (in fact 2.4 keV X-rays have an attenuation length of ~0.1 mm in tissue). Using the paper's numbers — Nph≈3e11 s^-1, t=600 s, ħω≈4e-16 J — the incident energy is ≈0.07 J; spread over ρV with V=1e-7 m^3 and ρ=1e3 kg/m^3, this is ≈700 Gy (≈180 Gy even with the paper's ρ=4e3 kg/m^3). Thus the actual PXR dose is hundreds of Gy, not 1.3 Gy. Therefore the claimed reduction relative to conventional sources does not follow; the conclusion that PXR is a safe selective therapy is unsupported.","agreement_with_reader":"agree"},"referee_report":{"model":"deepseek-v4-flash","summary":"The paper proposes using parametric X-ray radiation (PXR) tuned to the sulfur K-edge (2.4 keV) for selective radiation therapy of superficial tumors with elevated sulfur content. It derives the required photon flux, estimates the PXR output (Nph ≈ 3e11 ph/s), and calculates the resulting ionization fraction and total absorbed dose, claiming that PXR delivers about 1.3 Gy, two orders of magnitude lower than conventional X-ray tubes.","tokens_in":6507,"tokens_out":4398,"duration_ms":36627,"significance":"If correct, this would be a novel, compact, and selective radiotherapy modality. The authors make a transparent analytic estimate based on published cross-sections and PXR formulas, which is a strength. However, the central dose calculation (Eq. 29–31) is physically inappropriate and reverses the claimed dose advantage. The paper also contains internal numerical inconsistencies. The manuscript therefore does not currently support its main conclusion.","major_comments":[{"comment":"The absorbed dose is computed using the thermal-diffusion volume V≈8(at)^{3/2}, but photon energy is deposited in the beam-irradiated volume, approximately ΣL. Using the paper's own numbers (ℏωK≈4e-16 J, Nph≈3e11 s^-1, t=600 s, Σ≈1 cm², L≈1 mm, ρ≈4e3 kg/m³), D = ℏωK Nph t / (ρΣL) ≈ 180 Gy, not 1.3 Gy. With a more realistic attenuation length of ~0.1 mm at 2.4 keV, the dose is even higher. Thus Eq. (31) and the claimed two-orders-of-magnitude dose reduction versus X-ray tubes are unsupported.","section":"§IV, Eqs. (29)–(31)"},{"comment":"The resonant cross-section is given as σ0 ≈ 9.2×10^{-20} cm² in Eq. (7), but §IV uses σ0 ≈ 1.1×10^{-19} cm². This inconsistency affects estimates in Eqs. (26)–(28) and the flux requirement; the source of either value should be clarified and the correct value used consistently.","section":"Eq. (7) vs. §IV"},{"comment":"The stated ionization fraction Ni ≈ 3×10^{-4} N0 does not follow from the preceding formulas. Substituting σ0 = 1.1×10^{-19} cm², Nph = 3×10^{11} s^{-1}, t = 600 s, and Σ = 1 cm² into Eq. (27) gives Ni/N0 ≈ 2×10^{-5}, an order of magnitude smaller. This does not change the qualitative conclusion because 2×10^{-5} > 10^{-7}, but the numerical claim is incorrect.","section":"§IV, Eqs. (26)–(28)"},{"comment":"The text refers to 'the critical concentration (23), N_cr_i(D)∼10^{-7}' but no Eq. (23) defines such a quantity; Eq. (23) in the manuscript is the PXR photon-rate formula. The comparison to the critical concentration is therefore unverifiable as written.","section":"§IV, reference to 'critical concentration (23)'"}],"minor_comments":[{"comment":"The assumed penetration depth L ~ 1 mm for 2.4 keV X-rays should be justified; near the sulfur K-edge, the attenuation length in tissue is typically closer to 0.1 mm. The conclusion depends on this value.","section":"§IV, first paragraph"},{"comment":"The approximation M = m_S N_S0 treats the tumor mass as pure sulfur. For real tissue this overestimates the dose for a given photon flux and should be stated as an upper-limit assumption.","section":"Eq. (10)"},{"comment":"The equation numbering is inconsistent: the text mentions 'critical concentration (23)', but Eq. (23) is the PXR intensity formula. Re-number or correct the cross-references.","section":"General"},{"comment":"Minor typos: 'Spectra photo-ionisation of S' and 'Scheme of the PXR generation' should be corrected, and the axis label in Fig. 2 ('σ, Mb , a.u.') is unclear.","section":"Figure captions"}],"recommendation":"reject","confidential_remarks":"The central dose calculation (Eq. 29) uses a heat-diffusion volume instead of the radiation-deposition volume, which flips the quantitative conclusion. Along with the internal factor-of-15 discrepancy in the ionization fraction and the inconsistent cross-section values, the manuscript's core claims are not reliable. I recommend rejection."},"author_rebuttal":null,"desk_editor":{"model":"deepseek-v4-flash","letter":"Quick take: the idea is real but the quantitative case does not survive contact with the paper's own equations. Applying 25 MeV PXR tuned to the sulfur K-edge as a compact alternative to synchrotron K-edge therapy is a genuinely new parameter proposal; the PXR flux estimate (Nph≈3×10^11 ph/s) is a reasonable ballpark for the stated beam. I'll credit that.\n\nThe problem is the dose. Eq. (29) divides the incident photon energy by ρV, with V from Eq. (30), a heat-conduction volume V≈8(at)^{3/2}. Radiation dose is not distributed over a volume set by thermal diffusion. The energy is deposited in the beam cross section times the penetration depth, roughly ΣL. With Σ≈1 cm^2 and L≈1 mm (and 2.4 keV X-rays in tissue probably penetrate less), V≈10^-7 m^3, not ~10^-4 m^3. That makes the '1.3 Gy' a factor of hundreds too low; the same parameters give hundreds of Gy. The claimed two-orders-of-magnitude advantage over an X-ray tube is therefore not supported.\n\nSmaller issues reinforce this: σ0 is quoted as 9.2×10^-20 cm^2 in Eq. (7) and 1.1×10^-19 cm^2 in Section IV; Eq. (28) says Ni/N0≈3×10^-4, but Eq. (27) with the paper's own numbers gives about 2×10^-5; and the 'critical concentration' is referenced as Eq. (23), which is actually the PXR photon rate. The 3× sulfur enrichment is cited from the literature, which is fine as a starting assumption, but it is not made specific to the tumor types claimed.\n\nWho gets value: someone scoping whether a compact PXR source could serve very superficial K-edge therapy will find the source-side estimates worth reading. The therapy-side numbers should be treated as an exercise, not a result.\n\nI would not desk-reject it out of hand—there is a concrete proposal and the errors are fixable—but a serious referee should ask for the dose to be recomputed with deposition volume, the numerical inconsistencies resolved, and the conclusions softened accordingly. If that happens, the remaining claim might still be useful for very superficial lesions. As written, I would not cite the dose numbers.","headline":"PXR for sulfur K-edge is a plausible new application, but the dose estimate uses the wrong volume and the central comparison to X-ray tubes collapses.","tokens_in":6987,"tokens_out":5206,"would_cite":false,"duration_ms":43568,"reading_group":"maybe","serious_thinker":"no","would_accept_peer_review":true},"rs_alignment":null,"lean_confirmation":null,"pith_extraction":{"msc":[],"pacs":["41.59.+h","82.59.-m","87.59.-e"],"model":"deepseek-v4-flash","headline":"The paper claims PXR tuned to the sulfur K-edge can selectively ionize sulfur atoms in superficial tumors, delivering about 1.3 Gy versus 100 times more from a conventional X-ray tube.","keywords":["parametric X-ray radiation","sulfur K-edge","resonant photoionization","selective cancer therapy","radiation dose","superficial tumors","medical accelerators"],"falsifier":"Measure the dose-depth profile of a 2.4 keV PXR beam in a tissue-equivalent material: if the absorbed dose in a 1 cm² target of 1 mm thickness exceeds ~100 Gy over 600 s, the 1.3 Gy estimate is wrong because the volume assumption in Eq. (30) fails.","tokens_in":6023,"feed_emoji":"🩻","tokens_out":5326,"duration_ms":82364,"temperature":0.7,"pith_summary":"The paper sets out to show that parametric X-ray radiation (PXR) — X-rays produced when electrons pass through a crystal — can be tuned to the 2.4 keV K-absorption edge of sulfur and serve as a selective therapy for superficial sulfur-containing tumors. Since tumor cells carry roughly three times more sulfur than healthy cells, resonant absorption by sulfur atoms should damage tumors preferentially. The authors estimate a PXR source delivers about 1.3 Gy for a 600-second session, while a conventional X-ray tube needs about 100 times that dose for the same effect. If correct, this makes selective resonance therapy possible with compact 20–40 MeV medical accelerators.","feed_headline":"Tuning X-rays to sulfur could shrink tumor therapy dose 100-fold","feed_subtitle":"Parametric X-ray radiation at 2.4 keV targets sulfur-rich tumors, delivering about 1.3 Gy instead of ~100 Gy.","key_machinery":"The mechanism is resonant photoionization at the sulfur K-edge driven by parametric X-ray radiation. PXR is generated when an electron bunch passes through a crystal; its spectral peak is set by crystal orientation via sinθ_B = πc/(dω_K), and its bandwidth and divergence scale as γ⁻¹. This gives a tunable, quasi-monochromatic X-ray source whose frequency matches the sulfur absorption line. The selectivity is quantified by K(D) ≈ 3, reflecting the threefold higher sulfur concentration in tumor cells.","core_discovery":"The central claim is that PXR photons from a 25 MeV electron beam in a silicon crystal can be tuned to the sulfur K-edge at 2.4 keV by setting the crystal angle to θ_B ≈ 51.26°. Because the beam is quasi-monochromatic (Δω/ω ≈ 10⁻²) and narrow (Δθ ≈ 10⁻²), essentially only sulfur atoms absorb it. The estimated flux of ~3×10¹¹ photons per second ionizes about 3×10⁻⁴ of the sulfur atoms in a tumor after 600 s, exceeding the critical concentration for irreversible tumor damage. The total absorbed dose is then about 1.3 Gy, two orders of magnitude below the dose from a conventional X-ray tube for the same biological effect.","pith_inferences":["One extension not made in the paper: the dose calculation in Eq. (30) uses a thermal-diffusion volume of V ≈ 8(at)^{3/2}. If instead the dose is deposited in the much smaller X-ray attenuation volume — 2.4 keV photons penetrate only about 0.1 mm in tissue — the actual absorbed dose would be far higher than 1.3 Gy, potentially hundreds of Gy. This is a testable correction, not a claim of the paper.","The selectivity claim implicitly assumes that sulfur K-shell ionization reliably triggers tumor-cell death; an in vitro survival assay on sulfur-rich versus normal cell lines under 2.4 keV narrow-band irradiation would directly test this.","A tunable PXR source could also target other biologically relevant K-edges in the 2–10 keV range, such as calcium or phosphorus, if a tumor type shows a concentration differential for those elements."],"forward_implications":["Medical accelerators in the 20–40 MeV range could act as compact PXR sources, removing the need for GeV-scale synchrotron facilities for this kind of selective therapy.","Superficial tumors with elevated sulfur content could be treated with an integral dose near 1 Gy, reducing collateral damage to healthy tissue.","The estimated PXR flux of ~3×10¹¹ ph/s exceeds the source requirement of ~10⁸ ph/s by a wide margin, giving practical headroom for beam shaping and delivery losses.","If the K(D) ≈ 3 selectivity holds in vivo, the therapeutic ratio for sulfur-rich tumors would be roughly three times better than for non-selective irradiation."],"fun_headline_variants":[],"cache_read_input_tokens":2304,"weakest_assumption_plain":"The entire dose comparison hinges on the assumption that the absorbed energy spreads through a thermal-diffusion volume V ≈ 8(at)^{3/2} with a = 10⁻⁶ m²/s; if the energy stays in the much smaller X-ray penetration volume, the dose is no longer 1.3 Gy and the claimed advantage over X-ray tubes disappears.","fun_headline_variants_meta":{"error":"'choices'"},"cache_creation_input_tokens":0},"created_at":"2026-08-04T11:36:58.182893+00:00","model_set":{"reader":"deepseek-v4-flash"},"falsifier":"Measure the dose-depth profile of a 2.4 keV PXR beam in a tissue-equivalent material: if the absorbed dose in a 1 cm² target of 1 mm thickness exceeds ~100 Gy over 600 s, the 1.3 Gy estimate is wrong because the volume assumption in Eq. (30) fails.","supporting_citations":[],"review_version":1}